Pre-clinical anti-tumour activity of LGR5-specific CAR T-cells has recently been demonstrated in models of ovarian cancer [135], while LGR5-specific CAR NK cells have also been described [136]. This evidence concerns the gene LGR5 and ovarian cancer.